Skip to content

POWERFLEX 4401202SRecalls & reported problems

Cordis US Corp. · POWERFLEXPRO 12MM2CM 80 · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 20705032060131), received between Jan 23, 2019 and Jan 23, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Burst Container or Vessel1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 23, 2019Burst Container or Vessel; Burst Container or Vessel

    AS REPORTED, THE 12MM X 2CM POWERFLEX PRO PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER (BC) WAS INSERTED AND INFLATED AFTER A NON-CORDIS 6MMX4CM BC WAS INFLATED, HOWEVER THE POWERFLEX PRO RUPTURED AT EIGHT ATMOSPHERES. NO PATIENT INJURY WAS REPORTED. THIS WAS A SHUNT CASE. THE LESION WAS THE LEFT SUBCLAVIAN VEIN WHICH HAD STENOSIS. AN APPROACH WAS MADE FROM THE LEFT BRACHIAL PART WITH A NON-CORDIS 7F SHEATH. A NON-CORDIS GUIDEWIRE CROSSED THE LESION. AFTER THE POWERFLEX PRO RUPTURED, IT WAS REPLACED WITH A NEW NON-CORDIS 10MMX4CM BC AND THE PROCEDURE WAS COMPLETED. THE DEVICE HAS BEEN DISCARDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8271703 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.